ORAMED PHARMACEUTICALS INC.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Schedule 14A

Proxy Statement Pursuant to Section 14(a) of

the Securities Exchange Act of 1934

Check the appropriate box:

Oramed Pharmaceuticals Inc.

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

Dear Stockholder:

You are cordially invited to attend the 2026 Annual Meeting of Stockholders of Oramed Pharmaceuticals Inc. (the “Annual Meeting”) to be held at Oramed Pharmaceuticals Inc., 20 Mamilla Avenue, 3 rd Floor, Jerusalem, 9414904, IL, on September 15, 2026, at 10:00 a.m., Israel time.

Your vote is very important. Whether or not you expect to be present at the Annual Meeting, after receiving the Notice of Internet Availability and proxy card, please vote as promptly as possible to ensure your representation and the presence of a quorum at the Annual Meeting. As an alternative to voting during the Annual Meeting, you may vote online, by phone or by completing and returning the proxy card. Voting online, by phone or by written proxy ensures your representation at the Annual Meeting regardless of whether you attend the meeting. If your shares are held in the name of a broker, trust, bank or other nominee, and you receive printed copies of our proxy materials through your broker or through another intermediary, please complete and return the materials in accordance with the instructions provided to you by such broker or other intermediary or contact your broker directly in order to obtain a proxy issued to you by your nominee holder to attend the Annual Meeting and vote. Failure to do so may result in your shares not being eligible to be voted by proxy at the Annual Meeting. On behalf of the Board, I urge you to submit your proxy as soon as possible. If you have any questions regarding the proxy materials or would like directions to the Annual Meeting, please call 844-967-2633. You may also find directions athttps://www.oramed.com/investors/governance-documents/annual-shareholder-meeting.

Thank you for your support of our company. I look forward to seeing you at the Annual Meeting.

Sincerely,

/s/ Nadav Kidron

Nadav Kidron

Chief Executive Officer

IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR

THE STOCKHOLDER MEETING TO BE HELD ONSEPTEMBER 15, 2026:

Our official Notice of Annual Meeting of Stockholders, Proxy Statement and

2026 Annual Report to Stockholders are available at:

www.proxyvote.com

NOTICE OF ANNUAL MEETING OF STOCKHOLDERS

To Be Held September 15, 2026

The 2026 Annual Meeting of Stockholders (the “Annual Meeting”) of Oramed Pharmaceuticals Inc., a Delaware corporation (the “Company”), will be held at Oramed Pharmaceuticals Inc., 20 Mamilla Avenue, 3 rd Floor, Jerusalem, 9414904, IL, on September 15, 2026, at 10:00 a.m., Israel time. We will consider and act on the following items of business at the Annual Meeting:

(1) Election of six directors to serve on our board of directors (the “Board”) for a term of one year or until their successors are elected and qualified, for which the following are nominees: Nadav Kidron, Dr. Miriam Kidron, Dr. Arie Mayer, Yehuda Reznick, Benjamin Shapiro, and Dr. Daniel Aghion (the “Director Election Proposal”);

(2) Ratification of the appointment of Kesselman & Kesselman, certified public accountants in Israel, a member of PricewaterhouseCoopers International Limited, as our independent registered public accounting firm for the fiscal year ending December 31, 2026 (the “Auditor Ratification Proposal”);

(3) Approval of the Third Amendment to the Oramed Pharmaceuticals Inc. Long-Term Incentive Plan, as amended, to increase the total number of shares of the Company’s common stock, par value $0.012 per share, authorized for issuance under such plan by 3,000,000, to a total of 12,500,000 shares (the “Incentive Plan Amendment Proposal”);

(4) Approval of, on a non-binding advisory basis, the compensation of our named executive officers (the “Say on Pay Proposal”);

(5) Approval of, on a non-binding advisory basis, the frequency of future advisory votes on the compensation paid to our named executive officers (the “Say on Frequency Proposal”);

(6) Approval of a proposal to adjourn the Annual Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of any one or more of the foregoing proposals (the “Adjournment Proposal”); and

(7) Such other business as may properly come before the Annual Meeting and any postponements thereof.

Stockholders are referred to the Proxy Statement available at the website listed above for more detailed information with respect to the matters to be considered at the Annual Meeting. After careful consideration, the Board recommends a vote “FOR” the Director Election Proposal, “FOR” the Auditor Ratification Proposal, “FOR” the Incentive Plan Amendment Proposal, “FOR” the Say on Pay Proposal, “EVERY THREE YEARS” for the Say on Frequency Proposal, and “FOR” the Adjournment Proposal.

The Board has fixed the close of business on July 20, 2026, as the record date for the Annual Meeting (the “Record Date”). Only holders of record at the close of business on the Record Date of shares of our Common Stock are entitled to vote at the Annual Meeting or at any postponement(s) or adjournment(s) of the Annual Meeting. A complete list of registered stockholders entitled to vote at the Annual Meeting will be available for inspection at the office of the Company during regular business hours for the 10 calendar days prior to and during the Annual Meeting.

You can vote by use of the proxy card mailed to you, or via the Internet or telephone as indicated on your proxy card, Notice of Internet Availability or voting instruction form. If you hold shares of Common Stock, as the stockholder of record on the Record Date, then you have the right to vote those shares at the Annual Meeting. If you are a beneficial owner and hold such shares in street name, then you can vote the shares you beneficially own through the online voting platform under a legal proxy from your bank, brokerage firm or other nominee and are not required to take any additional action to obtain a legal proxy.

Whether or not you expect to attend the Annual Meeting, we urge you to vote your shares as promptly as possible by Internet, telephone or mail so that your shares may be represented and voted at the Annual Meeting.

YOUR VOTE AND PARTICIPATION IN THE COMPANY’S AFFAIRS ARE IMPORTANT. TO ENSURE THAT YOUR SHARES ARE REPRESENTED AT THE ANNUAL MEETING. PLEASE VOTE IN ONE OF THESE WAYS:

• USE THE TOLL-FREE NUMBER shown on your proxy card; or

• VISIT THE WEBSITE noted on your proxy card to vote via the Internet.; or

• MARK, SIGN, DATE AND PROMPTLY RETURN your proxy card in the postage-paid envelope.

STOCKHOLDERS WHO ATTEND THE ANNUAL MEETING MAY REVOKE THEIR PROXIES AND VOTE IN PERSON IF THEY DESIRE.

If your shares are held in the name of a broker, trust, bank or other nominee, and you receive printed copies of our proxy materials through your broker or through another intermediary, please complete and return the materials in accordance with the instructions provided to you by such broker or other intermediary or contact your broker directly in order to obtain a proxy issued to you by your nominee holder to attend the Annual Meeting in person and vote. Failure to do so may result in your shares not being eligible to be voted by proxy at the Annual Meeting.

By Order of the Board of Directors,

/s/ Nadav Kidron

Nadav Kidron

Chief Executive Officer